Association of Clinical Researchers and Educators: Claiming Lost Ground -- Advancing Patient Care
ACRE is an organization of physicians and colleagues engaged in promoting excellence in medical service, education, and innovation. ACRE members have records of achievement in these endeavors.
The second ACRE meeting took place at the Weill Cornell Medical Center in New York City, New York. This year’s ACRE 2011 meeting covered a number of areas and topics and included speakers and representatives from across the health care industry. Slides and presentation materials are posted on the meeting site. Topics included:
- The History of the Conflict of Interest “Mania”
- Issues in the field of continuing medical education (CME)
- Why Academia/Industry Collaboration is under attack
- Academic Medical Centers
- The Importance of Academic-Industry Collaboration for Patients; and
- Washington and Innovation
The meeting was covered by the New York Times, which noted how the conference started by addressing the term “conflicts of interest.” Several presenters noted that, “conflict of interest” is a “pejorative term” and that a better term is “overlap of interests,” because the drug and device companies want to market products to help people, and the researchers and professors want to help them find new cures and spread the word.
Another panel during the meeting looked at why academic-industry collaboration is under attack by not only “politicians, deans and the media” but also medical journal editors, the Association of American Medical Colleges, the Institute of Medicine of the National Academy of Sciences, the National Institutes of Health, the American Medical Association, the United States Department of Justice, and of course the media.
Dr. Thomas P. Stossel, a Harvard medical professor and co-founder of the group, said that drug companies, years ago, reported their financial support for professors and researchers to honor them.
“Now, it’s a confession of guilt,” he said of the lengthy financial disclosures that many speakers flashed on the screen. Most of them said the industry support proved their value.
He noted that several academic organizations that received media in their announcements of strict policies have since backed off these policies due to push back from faculty, the implacability of the proponents of the rules and difficulty of implementation of these strict policies.
Dr. J. Michael Gonzalez-Campoy, chief executive of a Minnesota obesity center and past president of that state’s medical association, said the growing pressure to disclose financial ties with drug and device makers is leading further, too far, to outright bans of such ties in the leadership of some medical societies.
The collaborative research and marketing, he said, help to bring drugs to patients that prolong and save lives.
Dr. Michael A. Weber, another cofounder of the group and professor of medicine at the SUNY Downstate Medical Center in Brooklyn, said ACRE plans to push back by drafting its own guidelines for what is proper in industry-academic collaborations.
A panel of grateful patients was led by Montel Williams, a former talk show host who is battling multiple sclerosis, raising funds for medical causes, and recently received experimental treatment with what he described as great success. It was encouraging that Montel pushed the audience to be proud of the work they do with the medical products industry and not cower back because of criticisms.
Mr. Williams urged the beleaguered professors and researchers to stand up to critics and make it clear they are life-savers.
“Do your job!” he said to applause.
The responsibility of ACRE is to re-establish the partnership of academia, industry, clinicians, and patients in the United States. Among its goals is educating the lay public as well as the medical community about the value to patients of the research and educational collaborations between academia and industry.
Another of ACRE’s main tasks is to set up codes of conduct or guidelines designed to ensure that relationships between academic physicians and industry are ethical and clearly targeted at improving outcomes for our patients. ACRE also represents a voice that is heard and quoted when these industry-academia relationships are attacked, as they have been in the past.
Additionally, ACRE provides education for health care professionals and patient advocates to empower them to fight those policies that undermine productive collaboration.” The organization is also charged with training our current and next generation physicians so they can promote true excellence in medical education and innovation.
It is the responsibility of physicians and organizations like ACRE to argue the value to patients of cooperation between academia and industry in medical education as well as in research.
The slides for many of the presentations are available on the ACRE website:
ACRE 2011 Slides (Underline and Green)
In the near future the full program will be available in streaming video and MP3 audio files.